Attached files

file filename
10-Q - FORM 10-Q - ELI LILLY & Coc59350e10vq.htm
EX-12 - EX-12 - ELI LILLY & Coc59350exv12.htm
EX-31.1 - EX-31.1 - ELI LILLY & Coc59350exv31w1.htm
EX-31.2 - EX-31.2 - ELI LILLY & Coc59350exv31w2.htm
EXCEL - IDEA: XBRL DOCUMENT - ELI LILLY & CoFinancial_Report.xls
EX-32 - EX-32 - ELI LILLY & Coc59350exv32.htm
EXHIBIT 11.   STATEMENT RE: COMPUTATION OF EARNINGS PER SHARE
(Unaudited)
Eli Lilly and Company and Subsidiaries
                                 
    Three Months Ended     Six Months Ended  
    June 30,     June 30,  
    2010     2009     2010     2009  
     
BASIC
                               
Net income
  $ 1,348.9     $ 1,158.5     $ 2,597.0     $ 2,471.6  
     
Average number of common shares outstanding
    1,099.2       1,094.6       1,098.8       1,094.4  
Contingently issuable shares
    4.6       2.6       5.0       2.8  
     
Adjusted average shares
    1,103.8       1,097.2       1,103.8       1,097.2  
     
Basic earnings per share
  $ 1.22     $ 1.06     $ 2.35     $ 2.25  
     
DILUTED
                               
Net income
  $ 1,348.9     $ 1,158.5     $ 2,597.0     $ 2,471.6  
     
Average number of common shares outstanding
    1,099.2       1,094.6       1,098.8       1,094.4  
Incremental shares — stock options and contingently issuable shares
    4.6       2.6       5.0       2.8  
     
Adjusted average shares
    1,103.8       1,097.2       1,103.8       1,097.2  
     
Diluted earnings per share
  $ 1.22     $ 1.06     $ 2.35     $ 2.25  
     
Dollars and shares in millions except per-share data.